DEA Cannabis

The Drug Enforcement Administration (DEA) is facing legal heat following accusations of unlawful communication with Smart Approaches to Marijuana (SAM), a leading opponent of the Biden administration’s plan to reschedule marijuana from Schedule I to Schedule III under the Controlled...

A Washington-based researcher has filed a lawsuit against the Drug Enforcement Administration (DEA), alleging multiple legal violations in the agency's process of rescheduling marijuana. As Forbes reported, the complaint, filed in the U.S. District Court for Western Washington, names the Department...

Congressman Earl Blumenauer, a Democrat from Oregon and co-chair of the Congressional Cannabis Caucus says he’s disappointed the U.S. Drug Enforcement Administration (DEA) chose to delay rescheduling of marijuana. "It is incredibly disappointing to see the DEA drag their feet on an issue...

The deadline for public comments on the federal government’s plan to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) concluded on July 22 with tens of thousands of statements. Overall sentiment? Positive for marijuana supporters. Cannabis-focused...

Denver, Colorado submitted its official public comment to the cannabis rescheduling process underway at the Department of Justice (DOJ), which oversees the DEA. City officials said there are significant lessons the federal government can learn from Denver's long-standing experience with cannabis...

Senators Fight For Cannabis Industry Access To Federal Small Business Administration Financing A group of Democratic Senators is urging the Senate Appropriations Subcommittee to level the playing field for the state-legal marijuana industry by adding to the Fiscal Year 2025 Financial Services and...

Three national leaders gathered Wednesday to discuss the impact of the Drug Enforcement Administration's historic move to reclassify cannabis as a less dangerous drug.  Removing marijuana from Schedule 1 – the same class as heroin, LSD, meth and ecstasy – to Schedule III along with...

Tuesday's news that the Drug Enforcement Agency (DEA) will move to reclassify marijuana as a less dangerous drug blew the industry and sent cannabis stocks high in the sky. And, while the move was generally praised by the majority of industry experts some ...

Biden Administration Official Denies Rumor That DEA Is Rescheduling Cannabis Anytime Soon  Adrian Snead, a partner in the Washington, D.C. office and member of the firm’s Government & Regulatory Affairs and Litigation Practice Groups, who also worked with SAFER Banking sponsor Sen. Jeff...

A Republican congressman Dr. Andy Harris is issuing a letter to the Drug Enforcement Agency (DEA) criticizing the Department of Health and Human Services' (HHS) recommendation to reclassify cannabis to Schedule III under the federal Controlled Substances Act (CSA), first reported Fox New Radio. ...

Sen. Kirsten Gillibrand (D-NY) is calling on the Biden administration to deschedule cannabis. During a Sunday press conference, Gillibrand urged the Attorney General and the Drug Enforcement Agency (DEA) to remove cannabis from the list of controlled substances.  At the moment, marijuana is...

The Department of Health and Human Services (HHS) said it will release full documents regarding the agency's recommendation to federally reschedule cannabis amid litigation over a Freedom of Information Act (FOIA) request that was filed by lawyer Matthew C. Zorn last year, writes Marijuana Moment....

The Drug Enforcement Administration (DEA) is proposing the production of higher amounts of THC, psilocybin and DMR for research in 2024. In a notice scheduled to be published in the Federal Register on Wednesday, the agency said it is raising the proposed amounts as a response to a...

The Drug Enforcement Administration (DEA) is warning pharmacies in Georgia that dispensing medical marijuana is not legal under federal law. Nearly two months after the Georgia Board of Pharmacy allowed independent pharmacies to dispense THC oils, in what was considered a historic...

The University of Mississippi has created a new online graduate program focusing on medical cannabis and dietary supplements, leaning on the university's long-standing reputation for expertise in both fields. Ole Miss was the only cultivator of research cannabis in the U.S. for five decades.   This...